Imagin Medical Inc.
IME
CNSX
| 06/30/2023 | 03/31/2023 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -3.41% | -1.70% | |||
| Depreciation & Amortization | 0.58% | 0.59% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -3.03% | -46.20% | |||
| Operating Income | 3.03% | 46.20% | |||
| Income Before Tax | 353.90% | -5,571.19% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 353.90% | -5,571.19% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 353.90% | -5,571.19% | |||
| EBIT | 3.03% | 46.20% | |||
| EBITDA | 3.58% | 49.74% | |||
| EPS Basic | 354.03% | -5,518.18% | |||
| Normalized Basic EPS | 353.62% | -5,428.57% | |||
| EPS Diluted | 354.03% | -5,518.18% | |||
| Normalized Diluted EPS | 353.62% | -5,428.57% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
